VIRAL COMPLICATIONS AFTER TRANSPLANTATION

被引:17
作者
GRIFFITHS, PD
机构
[1] Division of Communicable Diseases, Royal Free Hospital School of Medicine, London, NW3 2PF, Rowland Hill Street
关键词
D O I
10.1093/jac/36.suppl_B.91
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
All hospital patients are at risk of acquiring infections from visitors or staff members or by nosocomial transmission. Transplant patients have additional routes of acquisition which together represent the major source of infection. These are: reactivation of latent virus; transmission with the donor organ; and transmission by blood. A wide variety of viruses have been implicated, with the common feature that they establish either chronic or latent infection in the donor or recipient. The aim of this paper is to review the natural history, clinical features, diagnosis, prevention and treatment of each of these viral infections. A basic principle will be that the presence of specific antibodies in a donor or recipient before undergoing transplantation is a marker of latent virus within that individual. After transplantation, patients have impaired immune responses, thereby rendering serology unreliable for diagnostic purposes. Instead, methods which detect the virus directly in clinical material should be used.
引用
收藏
页码:91 / 106
页数:16
相关论文
共 64 条
[11]   HUMAN HERPESVIRUS-6 IN LUNG-TISSUE FROM PATIENTS WITH PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION [J].
CONE, RW ;
HACKMAN, RC ;
HUANG, MLW ;
BOWDEN, RA ;
MEYERS, JD ;
METCALF, M ;
ZEH, J ;
ASHLEY, R ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :156-161
[12]   REACTIVATION OF POLYOMAVIRUS IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
COTTERILL, HA ;
MACAULAY, ME ;
WONG, V .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (05) :445-445
[13]   HUMAN HERPESVIRUS-6 (HHV-6) INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS - EVIDENCE OF A MARROW-SUPPRESSIVE ROLE FOR HHV-6 INVIVO [J].
DROBYSKI, WR ;
DUNNE, WM ;
BURD, EM ;
KNOX, KK ;
ASH, RC ;
HOROWITZ, MM ;
FLOMENBERG, N ;
CARRIGAN, DR .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :735-739
[14]   CYTOMEGALO-VIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION SUCCESSFULLY TREATED WITH THE COMBINATION OF GANCICLOVIR AND HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN [J].
EMANUEL, D ;
CUNNINGHAM, I ;
JULESELYSEE, K ;
BROCHSTEIN, JA ;
KERNAN, NA ;
LAVER, J ;
STOVER, D ;
WHITE, DA ;
FELS, A ;
POLSKY, B ;
CASTROMALASPINA, H ;
PEPPARD, JR ;
BARTUS, P ;
HAMMERLING, U ;
OREILLY, RJ .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) :777-782
[15]   HAIRY LEUKOPLAKIA AFTER BONE-MARROW TRANSPLANTATION [J].
EPSTEIN, JB ;
SHERLOCK, CH ;
WOLBER, RA .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1993, 75 (06) :690-695
[16]   ISOLATION OF A NEW HERPESVIRUS FROM HUMAN CD4+ T-CELLS [J].
FRENKEL, N ;
SCHIRMER, EC ;
WYATT, LS ;
KATSAFANAS, G ;
ROFFMAN, E ;
DANOVICH, RM ;
JUNE, CH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :748-752
[17]   PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALO-VIRUS INFECTION IN INFANTS BY BLOOD FILTRATION TO REMOVE LEUKOCYTES [J].
GILBERT, GL ;
HUDSON, IL ;
HAYES, K ;
JAMES, J .
LANCET, 1989, 1 (8649) :1228-1231
[18]   GANCICLOVIR PROPHYLAXIS TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC MARROW TRANSPLANT [J].
GOODRICH, JM ;
BOWDEN, RA ;
FISHER, L ;
KELLER, C ;
SCHOCH, G ;
MEYERS, JD .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :173-178
[19]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607
[20]  
GRUNDY JE, 1988, LANCET, V2, P132